UCB (EBR:UCB) UCB Media Room: Disposals of own shares

Transparency directive : regulatory news

18/12/2020 20:01

https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513= 9PTmAm2ORJ-2Fb7C-2B6en0A7bN4GxntdZLoJwtUSZVXmv5iau1Fg6fae5G0LBVEf-2F9ykVgi6= TaTUTQcaer1qQoM4QpAc6LO-2FvtXXVCt6V-2B5gdN_xDPID0vOuylFAU8fv4e60wei4JxqEGBd= VWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9= c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6-2Btiy0z3jp66Z-2Fe3Zqc= mHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BHnSNHCXELHkDhwUg4QReX2HBV75Ue8OV97VlEXFiUu= MjPihSG6ERDO-2FEyrUAC-2Fqy4tO7bk5Dkv76CVIewUdHasWmG4QNvwXWCTGsooZAXIIfxJToU= fvE-2BQNbcnmAX1hOncBcYOgqI6UQv3gaJ84NdKt823b4Cs-3D ** Disposals of own shares ------------------------------------------------------------ Brussels (Belgium), 18 December 2020 =E2=80=93 20:00 (CET) =E2=80=93 regula= ted information In accordance with article 8:6 of the Royal Decree executing the Belgian Co= de of Companies and Associations, UCB=C2=A0SA/NV (=E2=80=9CUCB=E2=80=9D or = the =E2=80=9CCompany) (Euronext Brussels: UCB)=C2=A0announces that, followi= ng exercises of stock options by members of its personnel, it has disposed = of UCB shares OTC in view of deliveries of these shares to the relevant mem= bers of the personnel, within the framework of the Long Term Incentive Prog= ram of the UCB Group, as follows: https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb513= 9PTmAm2ORJ-2Fb7C-2B6en0A7bN4GxntdZLoJwtUSZVMUu-2FUmWhcYJdVZTDd0UURnd-2B-2BQ= z5VelYdJpXl-2F-2FCx9jRjbauQHUOj3TcqGK-2Fj16DXlgi_xDPID0vOuylFAU8fv4e60wei4J= xqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj= -2F2X9c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6-2Btiy0z3jp66Z-2= Fe3ZqcmHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BHnSNHCXEKpUSiIba4k9rj2BIr7R4cDHEJToz= KYHGfFUplcBEcIAe9vdNq-2Bxc-2BbJlx4nNzMu3v0Jz8uX6t8PlQsUQpnTPCwGjduuTQmkvBxt= w6uUKkr3m7ivkAjvQEz-2FIfLaJVJRexvwmEf7hRbaE9iC9QNIA8g-3D =C2=A0 This press release is available on UCB=C2=A0SA/NV=E2=80=99s website via the= following link. (https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM= 8iDZJQyQ53jATUXZJD59ZUodhGC-2FyJVE-2BjXw-2Fd0j1C70r-2FZ058zOLCiGbx-2FzvKhSz= xYKNx18dK5MiuQ-3D-3DaSfk_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46= DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waJ97nwGaL23X0= FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6-2Btiy0z3jp66Z-2Fe3ZqcmHDCsO6fgYo0KEOjbY= 5uUrzDmuDR7aY4BHnSNHCXEAyS9FpgCGagyvxh5Krk2wutXSho0t-2FHoomXZw8vjwcnfwhpigY= XPjbuQUo4ZL9G48Pq34VrnQyIJdZ2HtLFBOYatlyhq2gLN5rF0LUc7HrOMr8BKyWDZKRgj5dQf3= CGKi6-2BEcuQOk35G3z37V2Re24-3D =C2=A0 Investor Relations Antje Witte, Investor Relations, UCB T +32 2 559 94 14, antje.witte@ucb.com =C2=A0 Isabelle Ghellynck, Investor Relations, UCB T +32 2 559 95 88, isabelle.ghellynck@ucb.com About UCB UCB, Brussels, Belgium (www.ucb.com (https://u7061146.ct.sendgrid.net/ls/cl= ick?upn=3DTeZUXWpUv-2B6TCY38pVLo9iNXQpOzOpqt-2BlzP11Y08Xg-3DZBYH_xDPID0vOuy= lFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf= -2FOeoCOG9ekocVj-2F2X9c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6= -2Btiy0z3jp66Z-2Fe3ZqcmHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BHnSNHCXEA0pn38VZEU19= 3Ah-2FzuINg37bBCTpYZ6SO2NsqDLDF4Al4JjlhhpVUj7RSwk3ZFWamjEKO8OvcV7tQbVXOkpAz= jkrGA4EtG6X7ubSxNOorfLogMd6LKJeG6Q-2Frbp5ft8C5TLgYgUQuLhKMZ-2B4UYHle0-3D ) = is a global biopharmaceutical company focused on the discovery and developm= ent of innovative medicines and solutions to transform the lives of people = living with severe diseases of the immune system or of the central nervous = system. With 7 500 people in approximately 40 countries, the company genera= ted revenue of =E2=82=AC 4.9 billion in 2019. UCB is listed on Euronext Bru= ssels (symbol: UCB). Follow us on Twitter: @UCB_news Image Disposals of own shares - 18 December 2020 (https://u7061146.ct.sendgrid.ne= t/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6en0A7bN4Gxn= tdZLoJwtUSZVMUu-2FUmWhcYJdVZTDd0UURlgNYNA9uzABixHA72ppGcw-3DJ3P9_xDPID0vOuy= lFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf= -2FOeoCOG9ekocVj-2F2X9c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6= -2Btiy0z3jp66Z-2Fe3ZqcmHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BHnSNHCXECyGkVVNrf-2F= snqBzB3z97urepD4n6-2F0r08I1xg-2BJ6MtoGHVL-2BKyBIm633hnaOBZcArQ1UtOtb2g2pn1l= pknpAdlYeapYYVbIfrD8fybHLb-2BDhcq8cAuczw3W1BHXck83Ujvq2NcQ4Zj1oVZQ81e71KA-3= D GenericFile 201218 - Vervreemding van eigen aandelen (https://u7061146.ct.sendgrid.net/= ls/click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6en0A7bN4Gxntd= ZLoJwtUSZVyEoBKLuTNDESvlv6GWdbS3o4oI5YuqDAAETZhLrMoJc-3DqZZr_xDPID0vOuylFAU= 8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FO= eoCOG9ekocVj-2F2X9c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6-2Bt= iy0z3jp66Z-2Fe3ZqcmHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BHnSNHCXEL11cIlvdHgc3zer8= 7Vy5VWEFwCyK1LP-2FowqROt-2FzMJJUBSynXNAEqgmwxLeQEvfHUk6OvzHf-2FGGxpWxg-2F28= zBJ9rwEKETv5nHo0l51fduOg3mRvDhhmC4a74Yn3mNUxlRwNMzmHkTeIZEu2jNdGm8w-3D Gene= ricFile 201218 - Alie nation d actions propres (https://u7061146.ct.sendgrid.net/ls= /click?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6en0A7bN4GxntdZL= oJwtUSZVFLGg41JAcl779ZZfVLmJAADKZFXQpGIaikSAesZx7ps-3Djqnn_xDPID0vOuylFAU8f= v4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeo= COG9ekocVj-2F2X9c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6-2Btiy= 0z3jp66Z-2Fe3ZqcmHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BHnSNHCXEJy-2B2cdG3QsFcpf5U= -2B8pdtHjJuXBFrSsyuZ4IyXXnJS3sT2g-2FMgYQjRJF9M22x9YmBImO3-2BGyP6qXQbEt0-2FM= HJKxJcF-2BwUD-2BgS-2FwgAncIkoLRe2CTrJdISRPrpYyYRVxcMWh1AWLbyjhAUbCkQjAxgs-3= D GenericFile 201218 - Disposals of own shares (https://u7061146.ct.sendgrid.net/ls/click= ?upn=3D4tNED-2FM8iDZJQyQ53jATUb5139PTmAm2ORJ-2Fb7C-2B6en0A7bN4GxntdZLoJwtUS= ZVrrizOV07nmF1TGp0864SWMpnEVOkZLEQshLi7qeidEg-3DiVLe_xDPID0vOuylFAU8fv4e60w= ei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EFaZqddW-2FBZlGB52Zlf-2FOeoCOG9ek= ocVj-2F2X9c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl0i80yjT8So5H8TgpWD6-2Btiy0z3jp6= 6Z-2Fe3ZqcmHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BHnSNHCXEMOM9Q4P-2FqrMZQYuIzyXThx= X8G8CLwq138gSbY40JVVL2pMj-2FdtnGFy6c-2BfmQh1CR2RuxJCJtA6uz1DzN29a-2FgghrtB-= 2BEFD-2FwAfikndP1QVj2xPPogZYcc8yi4HrIrb6zTg4r01F53PYEpBZq7bGWNs-3D=0D =0D ______________________=0D If you would rather not receive future communications from UCB SA, please g= o to https://u7061146.ct.sendgrid.net/ls/click?upn=3D4tNED-2FM8iDZJQyQ53jAT= UeYfdhr1xEBQnaPhR2RKx1tfe2VKDZTewv5u80JomRcXIybRz7z5dgwCHzuKR3kpSWMy7UPrY8D= fAijpvKvlbkKjbYC4cwHeWfIZFsrOvRVJilDa87EjyXjMBdu72I9kBMm7f46S5yYS9lH0UKdZRU= M-3D-_sM_xDPID0vOuylFAU8fv4e60wei4JxqEGBdVWu7KiDwjI3b8sYN46DL86bSl0KxvPs6EF= aZqddW-2FBZlGB52Zlf-2FOeoCOG9ekocVj-2F2X9c9g1waJ97nwGaL23X0FFeRKruoJqX7M3Vl= 0i80yjT8So5H8TgpWD6-2Btiy0z3jp66Z-2Fe3ZqcmHDCsO6fgYo0KEOjbY5uUrzDmuDR7aY4BH= nSNHCXEDal-2BazqB0sbAk8VShelJCzo7o-2BnwqRTW-2FQaz91-2B17O7SrocWopSsQeZMEOMQ= pF7fLAjUxzLc0Dy-2BVcYBNEO1fbr54MpfWTLmpDWtIPm-2FmyMIlhxySqZiI6pvkNNGAK60Eth= RdkfbV5e2IdAI7Vi3kY-3D=0D UCB SA, All=C3=A9e de la Recherche, 60 ., Brussels, . B - 1070 Belgium=

UCB's latest news

23/04/2024 20:00

UCB (EBR:UCB) UCB Media Room: Disposals of own shares

Transparency directive : regulatory news

UCB's latest news

Other stories